The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

Could half of the people who qualify for Trump Accounts lose out? What parents need to do to make sure they're on track to ...

Artificial intelligence has dramatically expanded the toolkit available for reverse engineering, and in-house counsel might ...

No one in Congress should be so powerful as to dictate presidential appointments. As for the expansion of executive power, ...